LRRTM2

LRRTM2 is a postsynaptic leucine-rich repeat transmembrane protein that localizes to excitatory synapses and organizes excitatory synapse formation, strength, and plasticity (PMID:20064388, PMID:20064387). Its extracellular LRR domain induces presynaptic differentiation by binding specifically to α- and β-neurexins lacking an insert at splice site 4 (PMID:20064387, PMID:20064388); crystallography maps this trans-synaptic interaction to the concave LRR surface and shows it is Ca2+-dependent (PMID:26785044). Through this neurexin interface, LRRTM2 stabilizes AMPA receptors and positions them in register with presynaptic release sites: conditional knockout of LRRTM1/2 selectively reduces AMPAR-mediated transmission and impairs LTP, and rescue requires an intact neurexin-binding interface but not the intracellular tail (PMID:29784826). Acute cleavage of the extracellular domain rapidly disperses AMPAR nanoclusters from release sites before total receptor number falls, dissociating nano-positioning from receptor abundance as independent determinants of evoked strength (PMID:34417170). The C-terminal intracellular domain governs surface expression, synaptic confinement, and membrane diffusion via a YxxC motif together with a PDZ-binding motif, and LRRTM2 associates with PSD-95 (PMID:20064388, PMID:34498765, PMID:39394199). Endogenous tagging shows LRRTM2 occupies most synapses and its level correlates with PSD-95 and AMPAR content (PMID:39824639). Lrrtm2 transcription is induced by synaptic NMDA-receptor activity through a nuclear calcium–CaMKIV–CREB/CBP pathway acting on a promoter cAMP response element (PMID:25527504).

1. 2009 High

   Established LRRTM2 as a postsynaptic organizer that selectively builds excitatory synapses and sets their strength, answering whether it has a defined synaptic function.

   Evidence shRNA and lentiviral in vivo knockdown, immunostaining, electrophysiology, and domain deletion in hippocampal neurons; coculture synaptogenic assays

   PMID:20064387 PMID:20064388

   Open questions at the time

   • Did not identify the presynaptic receptor for the LRR domain
   • Mechanism linking LRRTM2 to AMPAR surface expression unresolved
2. 2009 High

   Identified the trans-synaptic ligand as SS4-lacking neurexins, defining the molecular basis for LRRTM2-induced presynaptic differentiation and distinguishing it from neuroligin-1.

   Evidence Affinity chromatography, cell-adhesion assays, and blocking with recombinant neurexin-1β

   PMID:20064387 PMID:20064388

   Open questions at the time

   • Did not resolve the structural binding interface
   • Did not establish how binding controls postsynaptic AMPARs
3. 2014 Medium

   Showed that Lrrtm2 is an activity-regulated gene, linking synaptic NMDA-receptor signaling to its transcription and explaining how its expression is tuned by activity.

   Evidence Activity induction with reporter constructs, pharmacological inhibition of CaMK/CBP, and calcium buffering in hippocampal neurons

   PMID:25527504

   Open questions at the time

   • Functional consequence of activity-dependent upregulation on synaptic strength not tested
   • Single-lab reporter dissection
4. 2016 High

   Resolved the atomic basis of neurexin binding, mapping the interaction to the concave LRR surface and confirming Ca2+ dependence.

   Evidence X-ray crystallography of thermostabilized mouse LRRTM2, protein engineering, binding affinity measurements, and synaptogenic assays

   PMID:26785044

   Open questions at the time

   • No co-crystal structure of the LRRTM2-neurexin complex
   • Did not address intracellular signaling
5. 2018 High

   Demonstrated through genetic knockout and domain-specific rescue that the neurexin-binding interface, not the cytoplasmic tail, drives AMPAR transmission and LTP in vivo.

   Evidence Conditional LRRTM1/2 knockout, Cre lentivirus, patch-clamp, site-directed mutagenesis, and PAGFP-GluA1 photoactivation imaging

   PMID:29784826

   Open questions at the time

   • Redundancy between LRRTM1 and LRRTM2 not fully separated
   • Did not resolve subsynaptic positioning of AMPARs
6. 2021 High

   Separated AMPAR nano-positioning from receptor number as independent strength determinants by acutely severing the extracellular domain.

   Evidence Engineered TEV-based extracellular domain cleavage, STORM super-resolution microscopy, and evoked-versus-spontaneous EPSC recordings

   PMID:34417170

   Open questions at the time

   • Molecular link from the extracellular interaction to nanocolumn alignment not defined
   • Single lab
7. 2021 Medium

   Assigned synaptic confinement and membrane dynamics to a YxxC motif in the C-terminal tail, distinguishing its role from the PDZ-binding motif.

   Evidence shRNA knockdown, uPAINT single-molecule tracking, dSTORM, and C-terminal deletion/point mutants

   PMID:34498765

   Open questions at the time

   • Trafficking machinery engaging the YxxC motif unidentified
   • Single lab
8. 2022 Medium

   Showed LRRTM1/2 are developmentally required for excitatory synapse density and morphology and continuously required for LTP and fear memory.

   Evidence Double conditional knockout, electron/confocal microscopy, LTP electrophysiology, and fear conditioning

   PMID:35662394

   Open questions at the time

   • Phenotypes cannot be attributed to LRRTM2 alone due to double-KO design
   • Cell-type specificity beyond CA1/dentate not addressed
9. 2024 High

   Integrated extracellular and intracellular determinants, attributing presynaptic nano-organization and AMPAR sub-positioning to the neurexin interface and surface expression/clustering to selective C-terminal motifs.

   Evidence Conditional knockout, domain-specific mutants, super-resolution microscopy, and electrophysiology

   PMID:39394199

   Open questions at the time

   • Quantitative stoichiometry of LRRTM2-AMPAR coupling not defined
10. 2025 Medium

    Quantified endogenous LRRTM2 distribution, showing it occupies most synapses and scales with PSD-95 and AMPAR levels, including extrasynaptic AMPAR co-enrichment.

    Evidence Two-guide CRISPR knock-in of N-terminally tagged endogenous LRRTM2 in rat hippocampal neurons with quantitative imaging

    PMID:39824639

    Open questions at the time

    • C-terminal mutation raised LRRTM2 without matching AMPAR gain, leaving the coupling rule unexplained
    • Single lab
11. 2026 Low

    Proposed a non-canonical presynaptic role in which Bcl11a-dependent trafficking of Lrrtm2 to growth cone membranes governs axon targeting and circuit specificity.

    Evidence CPN-specific Bcl11a deletion, in vivo growth cone proteomics, localization validation, and projection tracing (preprint)

    PMID:41993341

    Open questions at the time

    • Preprint, not peer-reviewed
    • Limited direct mechanistic dissection of LRRTM2 in the growth cone
    • Whether the targeting role is direct or secondary to broad surface-protein mislocalization is unclear

• How the trans-synaptic neurexin interaction is mechanistically transduced across the membrane to align and stabilize AMPAR nanoclusters remains unresolved.
• No defined molecular chain linking extracellular neurexin binding to intracellular AMPAR anchoring
• No co-structure of the trans-synaptic complex
• Quantitative rule coupling LRRTM2 abundance to AMPAR content unexplained